CompletedPhase 2NCT01214187

Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Brigham and Women's Hospital
Principal Investigator: Rosas O Ivan, MD
Brigham and Women's Hospital
Intervention: inhaled carbon monoxide(drug)
Enrollment: 58 target
Eligibility: 18-85 years · All sexes
Timeline: 2011 – 2015

Study locations (8)

University of California San Francisco, San Francisco, California, United States
University of Illinois Chicago, Chicago, Illinois, United States
University of Chicago, Chicago, Illinois, United States
Tulane University, New Orleans, Louisiana, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
Columbia University, New York, New York, United States
University of Washington, Seattle, Washington, United States

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · University of California, San Francisco · University of Chicago · University of Illinois at Chicago · University of Michigan · Columbia University · Tulane University · University of Washington

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01214187 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials